Rubius Therapeutics, Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q2 2021 to Q3 2022

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Rubius Therapeutics, Inc. annual/quarterly Earnings Per Share, Basic history and growth rate from Q2 2021 to Q3 2022.
  • Rubius Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2022 was -0.7 USD/shares, a 27.3% decline year-over-year.
  • Rubius Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -1.99 USD/shares, a 10.8% increase from 2021.
  • Rubius Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -2.23 USD/shares, a 7.21% decline from 2020.
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$1 $0 -27.3% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $0 +$0.07 +12.5% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-09
Q3 2021 -$1 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$1 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.